Gufic Biosciences Limited (GUFICBIO.NS) NSE
Currency In INR
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
AD
Currency In INR
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Employees
1491
First IPO Date
October 19, 2004
| Name | Title | Pay | Year Born |
| Pranav Jayesh Choksi | Chief Executive Officer & Whole Time Director | 7.36M | 1983 |
| Ami Naresh Shah | Senior Manager of Legal, Company Secretary & Compliance Officer | 892,958 | N/A |
| Pankaj Jayakumar Gandhi | Whole-Time Director | 1.92M | 1959 |
| Devkinandan Roonghta | Chief Financial Officer | 2.96M | 1965 |
| Jayesh Pannalal Choksi | Chairman & MD | 9.44M | 1954 |
| Avik Das | Investor Relations Officer | 0 | N/A |
| Pinak Padhya | Associate Vice President - Sales & Marketing | 0 | N/A |
| Sunil Desai | Head Human Resource Department | 0 | N/A |
| Ashok Dev | President of Operation | 0 | N/A |
| Nagesh Yarrabathina | Chief Operating Officer | 0 | N/A |
Gufic Biosciences Limited is an Indian enterprise dedicated to the manufacturing and marketing of active pharmaceutical ingredients (APIs), generic medications, and related support services. The company's API and bulk drug offerings include antifungals, anesthetics, immunosuppressants, and intermediates for antifungal treatments. It also produces lyophilized injectable pharmaceuticals, covering diverse therapeutic areas such as antibiotics, antifungals, cardiac care, infertility solutions, antivirals, and proton-pump inhibitors. Additionally, Gufic Biosciences provides pharmaceutical products under its Spark, Criti Care, and Ferti Care brands, as well as a line of herbal and personal care items. The company distributes its extensive product portfolio to hospital networks and medical facilities, and it exports its goods to over twenty countries globally. Established in 1970, Gufic Biosciences Limited is headquartered in Mumbai, India.